Curzio Research publishes market commentary for informational and educational purposes. The opinions expressed and market conditions when the content is published may change. It is not personalized investment advice or an offer to buy or sell securities. Investing involves risk, including possible loss of principal. Do your own research and consult a qualified investment professional before making investment decisions.
It’s Conference Season!
Welcome back to another episode of Wall Street Unplugged.As you may know, I’ve been reporting live from the 2018 Consumer Electronics Show this week. And I’ve got some interesting observations to report… But on this week’s show, we’re going to focus on another major conference investors shouldn’t overlook: the annual J.P. Morgan Healthcare Conference. It’s attended by 400-plus biotech companies and over 10,000 industry professionals. And today I’ve reached out to my No. 1 healthcare industry analyst, Marc Lichtenfeld, to give us the inside scoop.Marc is Chief Income Strategist at The Oxford Club. He’s covered the biotech and healthcare sectors for over a decade. Tune in as Marc talks about promising new drug development and innovation across the healthcare sector… and why he thinks biotech has finally reached an “inflection point.”Marc also reveals two small-cap biotech companies with untapped potential.Good Investing,Frank CurzioDownload Transcript
Have a question for Frank and Daniel,
submit it here: askcurzio.com
Follow Frank's
Wall Street Unplugged podcast
“I follow you. I’ve gotten amazing ideas for my shows from you.”
More Wall Street Unplugged
This earnings season will wreak havoc on the market
Approach earnings season with caution… and get ready for a pullback over the next 6 months. Plus, an offshore oil play and a power stock to buy… Will AI kill the American dream? … And should investors own index funds?
The cooler PCE isn’t the win you might think
The PCE came in cooler than expected—but there's a catch. Plus, what inflation means for the upcoming earnings season… Trump's meeting of AI leaders… Anthropic's S-1 is a joke… And not all upgrades and downgrades are equal.
Can inverse ETFs save you from a pullback?
Do inverse ETFs offer protection during a selloff? Plus, should you buy oil stocks now or wait for a pullback? … 2 power stocks to buy amid AI volatility… And a great trade setup in uranium.
Political headwinds can’t derail the AI trade
Forget politics: The AI power story is stronger than ever. Plus, breaking down the market volatility… What the PMI means for inflation… A diesel export ban? … BofA's year-end targets… And McDonald's (MCD) bleak Investor Day.
Is the selloff in financial stocks a warning sign?
Should investors be concerned about the selloff in financial stocks? … Are SMLs a headwind for data centers? … A Curzio Research matchmaking service… And why Anthropic is turning to the government.
The market is facing the perfect storm
The perfect storm to push stocks lower. Plus, how Warsh can help ease market fears… Why hyperscalers need to slow AI spending… JB Hunt (JBHT) just sounded the alarm on energy prices… And why did the Clarity Act fail?
Latest episodes
